Clinical Trial Update: Maintenance Therapy With Subcutaneous Bortezomib [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating maintenance therapy with subcutaneous bortezomib in multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: European Myeloma Network B.V. | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED